07.01.2013 Views

Sorted By Test Name - Mayo Medical Laboratories

Sorted By Test Name - Mayo Medical Laboratories

Sorted By Test Name - Mayo Medical Laboratories

SHOW MORE
SHOW LESS

You also want an ePaper? Increase the reach of your titles

YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.

TUP<br />

81792<br />

Interpretation: Triiodothyronine (T3) values >180 ng/dL in adults or >200 ng/dL in children are<br />

consistent with hyperthyroidism or increased thyroid hormone-binding proteins. Abnormal levels (high or<br />

low) of thyroid hormone-binding proteins (primarily albumin and thyroid-binding globulin) may cause<br />

abnormal T3 concentrations in euthyroid patients.<br />

Reference Values:<br />

> or =1 year: 80-190 ng/dL<br />

Clinical References: 1. Hay ID, Klee GG: Linking medical needs and performance goals: clinical<br />

and laboratory perspectives on thyroid disease. Clin Chem 1993;39:1519-1524 2. Klee GG: Clinical usage<br />

recommendations and analytic performance goals for total and free triiodothyronine measurements. Clin<br />

Chem 1996;42:155-159<br />

T3 (Triiodothyronine), Uptake, Serum<br />

Clinical Information: Thyroxine (T4) is the main thyroid hormone. It circulates in 2 forms, protein<br />

bound (99.05%) and free (0.05%). Free thyroxine (FT4) is the biologically active form. Both bound and<br />

free forms are measured by total T4 (TT4) assays. While TT4 is a relatively reliable indicator of T4 levels<br />

in the presence of normal binding proteins, it is not a reliable indicator when binding proteins are<br />

abnormal. For example, increases in thyroxine-binding proteins may cause increased TT4 levels despite<br />

normal FT4 levels and normal thyroid function. Hence, laboratory tests have been developed to<br />

compensate for the presence of abnormal types or quantities of thyroxine-binding proteins. These include<br />

the T3-Uptake test (also called T uptake), the free thyroxine index (FTI), and FT4 assays. This test,<br />

T3-Uptake, reflects the level of thyroid-binding globulin (TBG) that is bound by T4. For example, when<br />

TBG concentration is decreased, less TBG is available to bind labeled triiodothyronine (T3), and more<br />

labeled T3 reagent binds to the solid-phase material (increased T3 uptake). This is also the case in<br />

hyperthyroidism, where higher levels of T4 are present and bind with the TBG, effectively reducing the<br />

TBG available to bind with labeled T3. T3-Uptake and TT4 results are used to calculate the FTI, as an<br />

estimate of biologically active thyroxine (FT4) status. Factors affecting the accuracy of T3-Uptake and<br />

FTI include: -FTI is inaccurate when TBG concentration is very abnormal: underestimates FT4 when<br />

binding protein concentrations are low, overestimates when binding protein concentrations are high.<br />

-Abnormal types of binding proteins may cause abnormal results. -Results are changed by drugs or<br />

physical conditions that alter the patient's TBG levels, or drugs that compete with endogenous T4 and T3<br />

for protein-binding sites. Because of its increased accuracy, the FT4 assay (FRT4 T4 [Thyroxine], Free,<br />

Serum by immunoassay) is the preferred routine test.<br />

Useful For: As an estimate the amount of circulating free thyroxine, when in conjunction with total<br />

thyroxine results to calculate the free thyroxine index<br />

Interpretation: Values from this test (triiodothyronine: T3-Uptake) are used in conjunction with total<br />

thyroxine (T4) measurements to calculate the free thyroxine index (FTI): -FTI=(T4 concentration) x (%<br />

T3-Uptake)/100 The FTI is a normalized determination that remains relatively constant in healthy<br />

individuals and compensates for abnormal levels of binding proteins. Hyperthyroidism causes increased<br />

FTI and hypothyroidism causes decreased values. Many drugs, by competing with endogenous T4 and T3<br />

for protein-binding sites, may cause abnormal T3-Uptake and FTI even when no thyroid malfunction is<br />

present. Physical conditions that alter thyroid-binding globulin (TBG) levels may have similar effects (see<br />

Cautions).<br />

Reference Values:<br />

Males: 27-37%<br />

Females: 20-37%<br />

Clinical References: 1. Whitley RJ, Meikle AW, Watts NB: Thyroid function. In Tietz<br />

Fundamentals of Clinical Chemistry. Fourth edition. Edited by CA Burtis, ER Ashwood. Philadelphia,<br />

WB Saunders Company, 1996, pp 645-646 2. Klee GG, Hinz VS: The Ciba Corning ACS:180 Plus. In<br />

Immunoassay Automation: An Updated Guide to Systems. Edited by DW Chan, Associated Press, New<br />

York, 1996, pp 63-102<br />

Current as of January 4, 2013 7:15 pm CST 800-533-1710 or 507-266-5700 or <strong>Mayo</strong><strong>Medical</strong><strong>Laboratories</strong>.com Page 1696

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!